Staff
 
Rheumatology Clinic
Staff
Last Update
Dec. 15, 2017
 

Publications in International Journals

 
 
226.
Papagoras C, Voulgari PV, Drosos AA: Long-term use of adalimumab in the treatment of rheumatic diseases. Open Access Rheumatol Res Rev 1: 51-68, 2009.
(Impact factor: 0 - Citations: 1)
227.
Derdemezis CS, Filippatos TD, Voulgari PV, Tselepis AD, Drosos AA, Kiortsis DN: Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis. Fund Clin Pharmacol 23: 595-600, 2009.
(Impact factor: 2,372 Citations: 3)
 
228.
Tsifetaki N, Botzoris V, Alamanos Y, Argyriou E, Zioga A, Drosos AA: Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study. J Rheumatol 36: 1550-1551, 2009.
(Impact factor: 3,854 Citations: 6)
 
229.
Exarchou S, Voulgari P, Markatseli T, Zioga A, Drosos AA: Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol 38: 328-331, 2009.
(Impact factor: 2,507 Citations: 3)
 
230.
Sokka T, Kautiainen H, Pincus T, Toloza S, da Rocha Castelar Pinheiro G, Lazovskis J, Hetland ML, Peets T, Immonen K, Maillefert JF, Drosos AA, Alten R, Pohl C, Rojkovich B, Bresnihan B, Minnock P, Cazzato M, Bombardieri S, Rexhepi S, Rexhepi M, Andersone D, Stropuviene S, Huisman M, Sierakowski S, Karateev D, Skakic V, Naranjo A, Baecklund E, Henrohn D, Gogus F, Badsha H, Mofti A, Taylor P, McClinton C, Yazici Y: Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 68: 1666-1672, 2009.
(Impact factor: 8,111 Citations: 14)
 
231.
Hyphantis T, Tomenson B, Paika V, Almyroudi A, Pappa C, Tsifetaki N, Voulgari PV, Drosos AA, Pavlidis N, Creed F: Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders. Qual Life Res 18: 1029-1042, 2009.
(Impact Factor: 2,376 - Citations: 0)
 
232.
Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA: The role of tumor necrosis factor (TNF)- and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol 27: 645-648, 2009.
(Impact factor: 2,396 Citations: 2)
 
233.
Bai M, Tomenson B, Creed F, Mantis D, Tsifetaki N, Voulgari PV, Drosos AA, Hyphantis TN: The role of psychological distress and personality variables in the disablement process in rheumatoid arthritis. Scand J Rheumatol 38: 419-430, 2009.
(Impact factor: 2,507 Citations: 5)
 
234.
Karageorgaki ZT, Bertsias GK, Mavragani CP, Kritikos HD, Spyropoulou-Vlachou M, Drosos AA, Boumpas DT, Moutsopoulos HM: Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol 27 (suppl 52): S33-S39, 2009.
(Impact factor: 2,396 Citations: 0)
   
235.
Markatseli TE, Kaltsonoudis ES, Voulgari PV, Zioga A, Drosos AA : Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol 27: 996-998, 2009.
(Impact factor: 2,396 Citations: 2)
 
236.
Voulgari PV, Paschou S, Svarna E, Tsifetaki N, Drosos AA: Images in rheumatology. Transfusion-related acute lung injury during intravenous immunoglobulin treatment. J Rheumatol 37: 190-191, 2010.
(Impact factor: 3,854 Citations: 0)
 
237.
Drosos AA : Efficacy of intraarticular infliximab administration in patients with recurrent gonarthritis: comment on the article by van der Bijl et al (Letter). Arthritis Care Rer 62: 291-292, 2010.
(Impact factor: 4,152 Citations: 0)
 
238.
Papagoras C, Kitsos G, Voulgari PV, Zikou AK, Argyropoulou MI, Zioga A, Drosos AA: Periocular xanthogranuloma: A forgotten entity?Clin Ophthalmol 4: 105-110, 2010.
(Impact factor: 0 Citations: 0)
 
239.
Markatseli TE, Papagoras C, Drosos AA : Prognostic factors for erosive rheumatoid arthritis. Clin Exp Rheumatol 28: 114-123, 2010.
(Impact factor: 2,396 Citations: 5)
 
240.
Papagoras C, Voulgari PV, Drosos AA : Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis. Autoimmun Rev 9: 574-582, 2010.
(Impact factor: 6,368 Citations: 3)
 
241.
Saougou I, Markatseli TE, Voulgari PV, Drosos AA : Maintained clinical response of infliximab treatment in ankylosing spondylitis: A 6-year long-term study. Joint Bone Spine 77: 325-329, 2010.
(Impact factor: 2,250 Citations: 0)
 
242.
Tsifetaki N, Georgiadis A, Alamanos Y, Fanis S, Argyropoulou M, Drosos A : Subclinical atherosclerosis in scleroderma patients. Scand J Rheumatol 39: 326-329, 2010.
(Impact factor: 2,507 Citations: 0)
 
243.
Saougou I, Papagoras C, Markatseli TE, Voulgari PV, Drosos AA: A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review. Clin Rheumatol 29: 1455-1459, 2010.
(Impact factor: 1,668 Citations: 0)
 
244.
Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA: The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol 71: 382-385, 2010.
(Impact factor: 2,108 Citations: 2)
 
245.
Goulia P, Voulgari PV, Tsifetaki N, Drosos AA, Hyphantis T: Comparison of health-related quality of life and associated psychological factors between younger and older patients with established rheumatic disorders. Aging Ment Health 14: 819-827, 2010.
(Impact factor: 1,127 Citations: 0)
 
246.
Jawaheer D, Olsen J, Lahiff M, Forsberg S, Lahteenmaki J, da Silveira IG, Rocha FA, Magalhaes Laurindo IM, Henrique da Mota LM, Drosos AA, Murphy E, Sheehy C, Quirke E, Cutolo M, Rexhepi S, Dadoniene J, Verstappen SM, Sokka T: Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Clin Exp Rheumatol 28: 454-461, 2010.
(Impact factor: 2,396 Citations: 0)
 
247.
Saougou I, Markatseli TE, Papagoras C, Voulgari PV, Alamanos Y, Drosos AA: Sustained Clinical Response in Psoriatic Arthritis Patients Treated with Anti-TNF Agents: A 5-year Open-Label Observational Cohort Study. Semin Arthritis Rheum 2010.
(Impact factor: 0 Citations: 0)
 
248.
Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA: A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine 77: 411-413, 2010.
(Impact factor: 2,250 Citations: 1)
 
249.
Derdemezis CS, Filippatos TD, Voulgari PV, Tselepis AD, Drosos AA, Kiortsis DN: Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatment. Clin Exp Rheumatol 28: 880-883, 2010.
(Impact factor: 2,396 Citations: 0)
 
250.
Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA: Prognostic Factors of Radiological Damage in Rheumatoid Arthritis: A 10-year Retrospective Study. J Rheumatol 38 :44-52, 2011.
(Impact factor: 3,854 Citations: 0)
 
 
 
 
 
 
Announcements
20th Scientific Rheumatologists Meeting of NW Greece
Jan 19 & 20, 2018
Postgraduate Courses Rheumatology Clinic 2017-2018
Jan. 2018
Postgraduate Courses Rheumatology Clinic 2017-2018
Sep. 2017
19th Scientific Rheumatologists Meeting of NW Greece
Jan 20 & 21, 2017